iShares Dow Jones US Medical Dev. (BMV:IHI) Shares Acquired by Santori & Peters Inc.

Santori & Peters Inc. grew its stake in shares of iShares Dow Jones US Medical Dev. (BMV:IHI) by 96.9% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 2,205 shares of the company’s stock after purchasing an additional 1,085 shares during the period. Santori & Peters Inc.’s holdings in iShares Dow Jones US Medical Dev. were worth $530,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently made changes to their positions in IHI. Clal Insurance Enterprises Holdings Ltd purchased a new stake in shares of iShares Dow Jones US Medical Dev. during the first quarter valued at $55,567,000. CHURCHILL MANAGEMENT Corp purchased a new stake in iShares Dow Jones US Medical Dev. in the 1st quarter worth about $27,996,000. Q3 Asset Management purchased a new stake in iShares Dow Jones US Medical Dev. in the 1st quarter worth about $1,265,000. Joseph P. Lucia & Associates LLC purchased a new stake in iShares Dow Jones US Medical Dev. in the 1st quarter worth about $357,000. Finally, Migdal Insurance & Financial Holdings Ltd. lifted its stake in iShares Dow Jones US Medical Dev. by 16.5% in the 1st quarter. Migdal Insurance & Financial Holdings Ltd. now owns 362,013 shares of the company’s stock worth $83,817,000 after acquiring an additional 51,282 shares in the last quarter.

The firm has a 50-day moving average of $240.19. iShares Dow Jones US Medical Dev. has a one year low of $2,806.59 and a one year high of $3,563.30.

Read More: How a Put Option Works

Institutional Ownership by Quarter for iShares Dow Jones US Medical Dev. (BMV:IHI)

Receive News & Ratings for iShares Dow Jones US Medical Dev. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for iShares Dow Jones US Medical Dev. and related companies with MarketBeat.com's FREE daily email newsletter.